Jodas Expoim Private Limited — Imatinib Exporter Profile
Indian Pharmaceutical Exporter · #4 for Imatinib · $1.9M export value · DGFT Verified
Jodas Expoim Private Limited is the #4 Indian exporter of Imatinib with $1.9M in export value and 38 verified shipments. Jodas Expoim Private Limited holds a 6.5% market share in Imatinib exports across 3 countries. The company exports 33 pharmaceutical products worth $24.4M across 8 therapeutic categories.
Jodas Expoim Private Limited — Imatinib Export Profile: Buyers & Destinations
Where Does Jodas Expoim Private Limited Export Imatinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $903.4K | 25 | 91.8% |
| SRI LANKA | $76.7K | 12 | 7.8% |
| BOLIVIA | $3.6K | 1 | 0.4% |
Jodas Expoim Private Limited exports Imatinib to 3 countries. The largest destination is RUSSIA accounting for 91.8% of Jodas Expoim Private Limited's Imatinib shipments, followed by SRI LANKA (7.8%) and BOLIVIA (0.4%). These destinations reflect Jodas Expoim Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Imatinib from Jodas Expoim Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| OOOJODAS EXPOIM | RUSSIA | $339.3K | 12 |
| OOO"JODAS EXPOIM" | RUSSIA | $314.1K | 8 |
| OOO JODAS EXPOIM | RUSSIA | $200.0K | 4 |
| M/S. OOO JODAS EXPOIM.. | RUSSIA | $50.0K | 1 |
| SOFTCARE INTERNATIONAL(PRIVATE)LIMITED | SRI LANKA | $33.9K | 2 |
| SOFTCARE INTERNATIONAL(PVT)LTD | SRI LANKA | $32.3K | 7 |
| SOFTCARE INTERNATIONAL (PVT) LTD | SRI LANKA | $8.7K | 1 |
| SYROS CORP | BOLIVIA | $3.6K | 1 |
| SOFTCARE INTERNATIONAL PVT LTD | SRI LANKA | $1.7K | 2 |
Jodas Expoim Private Limited supplies Imatinib to 9 buyers globally. The largest buyer is OOOJODAS EXPOIM (RUSSIA), followed by OOO"JODAS EXPOIM" (RUSSIA) and OOO JODAS EXPOIM (RUSSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Imatinib Export Value and How Much Does Jodas Expoim Private Limited Contribute?
India exported $18.5M worth of Imatinib through 1,726 shipments from 224 suppliers to 119 countries, serving 456 buyers globally. Jodas Expoim Private Limited contributes $1.9M to this total, accounting for 6.5% of India's Imatinib exports. Jodas Expoim Private Limited ships Imatinib to 3 countries through 9 buyers.
What Is the Average Shipment Value for Jodas Expoim Private Limited's Imatinib Exports?
Jodas Expoim Private Limited's average Imatinib shipment value is $50.0K per consignment, based on 38 shipments totaling $1.9M. The largest destination is RUSSIA (91.8% of Jodas Expoim Private Limited's Imatinib exports).
How Does Jodas Expoim Private Limited Compare to Other Indian Imatinib Exporters?
Jodas Expoim Private Limited ranks #4 among 224 Indian Imatinib exporters with a 6.5% market share. The top 3 exporters are CIPLA LIMITED ($5.2M), EUGIA PHARMA SPECIALITIES LIMITED ($4.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.9M). Jodas Expoim Private Limited processed 38 shipments to 3 destination countries.
What Imatinib Formulations Does Jodas Expoim Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IMATINIB TABLETS 400MG (3X10'S ALU-ALU BLISTER PACK) | $100.0K | 2 |
| IMATINIB TABLETS 100MG (3X10'S ALU-ALU BLISTER PACK) (AS PER INVOICE) | $84.3K | 3 |
| IMATINIB TABLETS 100MG (3X10'S TABLETS)(AS PER INVOICE) | $81.3K | 2 |
| IMATINIB TABLETS 100MG 3X10'S TABLETS-4950 PACKS | $79.0K | 2 |
| IMATINIB TABLETS 100MG (3X10 TABLETS) - | $69.5K | 2 |
| IMATINIB TABLETS 100MG (3X10 TABLETS) (A | $50.0K | 1 |
| IMATINIB TABLETS 400MG (3X10 TABLETS) | $50.0K | 1 |
| IMATINIB TABLETS 400MG (3X10 S TABLETS)(AS PER INVOICE) | $50.0K | 1 |
| IMATINIB TABLETS 100MG (3X10S ALU-ALU BLISTER PACK) | $50.0K | 1 |
| IMATINIB TABLETS 400MG (3X10S ALU-ALU BLISTER PACK) | $50.0K | 1 |
Jodas Expoim Private Limited exports 27 distinct Imatinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IMATINIB TABLETS 400MG (3X10'S ALU-ALU BLISTER PACK) with 2 shipments worth $100.0K.
How Does Jodas Expoim Private Limited Compare to Nearest Imatinib Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | EUGIA PHARMA SPECIALITIES LIMITED | $4.1M | 82 | 2 | $50.0K |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.9M | 72 | 7 | $40.3K |
| 4 | JODAS EXPOIM PRIVATE LIMITED ★ | $1.9M | 38 | 3 | $50.0K |
| 5 | NATCO PHARMA LIMITED | $1.3M | 33 | 9 | $39.7K |
| 6 | INTAS PHARMACEUTICALS LIMITED | $857.6K | 19 | 6 | $45.1K |
Jodas Expoim Private Limited ranks #4 among 224 Indian Imatinib exporters. Average shipment value of $50.0K compared to the market average of $82.5K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Imatinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 314 | 18.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 17.4% |
| DELHI AIR CARGO ACC (INDEL4) | 235 | 13.6% |
| DELHI AIR | 142 | 8.2% |
| Bombay Air | 123 | 7.1% |
| HYDERABAD AIR | 69 | 4.0% |
| HYDERABAD ACC (INHYD4) | 61 | 3.5% |
| AHEMDABAD AIR | 35 | 2.0% |
What Other Advanced Oncology Products Does Jodas Expoim Private Limited Export?
Jodas Expoim Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Jodas Expoim Private Limited's Imatinib Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Jodas Expoim. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing significant delays and increased freight costs. These maritime disruptions have the potential to jeopardize up to ₹5,000 crore (approximately $600 million) in Indian pharmaceutical exports to the Middle East, a region that accounted for $1.75 billion in exports in the 2024-25 financial year. (pharmaceuticalcommerce.com)
Conversely, the U.S. has imposed tariffs on pharmaceutical imports, affecting nearly 55% of India's outbound shipments to America. This development necessitates strategic adjustments for exporters like Jodas Expoim to maintain competitiveness in the U.S. market. (apnews.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. The directive mandates stringent serialization and traceability requirements to combat counterfeit drugs. For Jodas Expoim, adhering to these regulations is crucial to sustain and expand its presence in the EU market.
Jodas Expoim Private Limited — Regulatory Compliance & Quality Standards
The Indian pharmaceutical industry has faced increased scrutiny from international regulatory bodies. In 2023, the U.S. FDA conducted over 200 inspections in India, with plans to increase this number in 2024. This heightened oversight underscores the necessity for companies like Jodas Expoim to invest in robust quality control systems and ensure compliance with Good Manufacturing Practices (GMP). (fact.net.in)
The 2024 incident involving the seizure of spurious antibiotics from Jodas Expoim's facility highlights the critical importance of maintaining stringent quality standards. Such regulatory lapses can have severe repercussions, including export bans and damage to the company's reputation.
About Jodas Expoim Private Limited
Jodas Expoim Private Limited exports 33 products worth $24.4M. Beyond Imatinib, top products include Paclitaxel, Capecitabine, Oxaliplatin, Gemcitabine, Temozolomide. View the complete Jodas Expoim Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Imatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Imatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Jodas Expoim Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 38 individual customs records matching Jodas Expoim Private Limited exporting Imatinib, covering 27 formulations to 3 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Imatinib Export Data from Jodas Expoim Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Jodas Expoim Private Limited's Imatinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Jodas Expoim Private Limited
Full Company Profile →
33 products · $24.4M total trade · 8 categories
Imatinib Stats
Company Overview
Top Products by Jodas Expoim Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Jodas Expoim Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imatinib. For current shipment-level data, contact TransData Nexus.